Apparently, Rh2E2 decreased energy production by suppressing aerobic glycolysis in cancer cells, and on the other hand, it arrested the cell cycle in S-phase with up-regulation of p53 and p27 and down-regulation of Skp2. The gene discussed is TP53; the disease is cancer.